Treatment algorithm use to optimize management of symptomatic patients with a history of mania

Journal of Clinical Psychiatry

Volumn 59, Issue 2, 1998, Pages 89-96

  Suppes, Trisha ^a,c   Rush Jr , A John ^a   Kraemer, Helena C ^b   Webb, Andrew ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

^c St Paul Professional Building 1 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; NEUROLEPTIC AGENT; VALPROATE SEMISODIUM;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; META ANALYSIS; MOOD; PRIORITY JOURNAL; RATING SCALE; SCHIZOIDISM;

EID: 0031888357     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0208     Document Type: Article

References (40)

1. Cooper JE, Kendell RE, Gurland BJ, et al. Psychiatric diagnosis in New York and London: a comparative study of mental hospital admissions. Maudsley Monograph No. 20. London, England: Oxford University Press; 1972
2. Pope HG Jr, Lipinski JF. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of "schizophrenic" symptoms in the light of current research. Arch Gen Psychiatry 1978;35:811-828
3. Aubert JL, Rush AJ. Schizoaffective disorder: a review for DSM-IV. In: Widiger TA, Frances AJ, Pincus HA, et al, eds. DSM-IV Sourcebook, vol 2. Washington, DC: American Psychiatric Press; 1996:65-96
4. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
5. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-924
6. Dickson WE, Kendell RE. Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychol Med 1986;16:521-530
7. Page C, Benaim S, Lappin F. A long-term retrospective follow-up study of patients treated with prophylactic lithium carbonate. Br J Psychiatry 1987; 150:175-179
8. Markar HR, Mander AJ. Efficacy of lithium prophylaxis in clinical practice. Br J Psychiatry 1989;155:496-500
9. O'Connell RA, Mayo JA, Flatow L, et al. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991;159:123-129
10. Peselow ED, Fieve RR, Difiglia C, et al. Lithium prophylaxis of bipolar illness: the value of combination treatment. Br J Psychiatry 1994;164: 208-214
11. Maj M, Pirozzi R, Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology (Berl) 1989;98:535-538
12. Guscott R, Taylor L. Lithium prophylaxis in recurrent affective illness: efficacy, effectiveness and efficiency. Br J Psychiatry 1994;161:741-746
13. Sernyak MJ, Woods SW. Chronic neuroleptic use in manic-depressive illness. Psychopharmacol Bull 1993;29:375-381
14. Chou JC-Y. Recent advances in treatment of acute mania. J Clin Psychopharmacol 1991;11:3-21
15. Keck PE Jr, McElroy SL, Vuckovic A, et al. Combined valproate and carbamazepine treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:319-322
16. Ketter TA, Pazzaglia PJ, Post RM. Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature. J Clin Psychopharmacol 1992;12:276-281
17. Tohen M, Castillo J, Pope HG Jr, et al. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders. J Clin Psychopharmacol 1994;14:67-70
18. Keck PE Jr, McElroy SL, Strakowski SM, et al. Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J Clin Psychiatry 1996;57:147-151
19. Fenn HH, Robinson D, Luby V, et al. Trends in pharmacotherapy of schizoaffective and bipolar affective disorders: a 5-year naturalistic study. Am J Psychiatry 1996;153:711-713
20. Jobson KO, Potter WZ. International Psychopharmacology Algorithm Project Report [introduction]. Psychopharmacol Bull 1995;313:457-459
21. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Bipolar Disorder. Am J Psychiatry 1994;151(12, suppl): 1-36
22. Rush AJ, Prien RF. From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? Psychopharmacol Bull 1995;31:7-20
23. Prien RF, Rush AJ. National Institute of Mental Health Workshop Report of the Treatment of Bipolar Disorder. Biol Psychiatry 1996;40:215-220
24. Licht RW, Gouliaev G, Vestergaard P, et al. Generalisability of results from randomised drug trials. Br J Psychiatry 1997;170:264-267
25. Janicak PG, Davis JM, Preskorn SH, et al. Principles and Practice of Psychopharmacotherapy. Baltimore, Md: Williams & Wilkins; 1993
26. Calabrese JR, Woyshville MJ. A medication algorithm for treatment of bipolar rapid cycling? J Clin Psychiatry 1995;56(suppl 3):11-18
27. Suppes T, Calabrese JR, Mitchell PB, et al. Algorithms for the treatment of bipolar, manic-depressive illness. Psychopharmacol Bull 1995;31 (suppl 3):469-474
28. Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1996;16:32S-47S
29. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R (SCID). New York, NY: Biometric Research, New York State Psychiatric Institute; 1987
30. Kosten TA, Rounsaville BJ. Sensitivity of psychiatric diagnosis based on the best estimate procedure. Am J Psychiatry 1992;149:1225-1227
31. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 1988;24:97-99
32. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
33. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. Journal of the American Statistical Association 1958;53:457-481
34. SAS Institute Inc. SAS/STAT Guide for Personal Computers, Proprietary Software Release, version 6.04. Cary, NC: SAS Institute; 1987
35. Coryell W, Scheftner W, Keller M, et al. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993;150:720-727
36. Krüger S, Bräunig P, Young LT. Biological treatment of rapid-cycling bi-polar disorder. Pharmacopsychiatry 1996;29:167-175
37. Desai NG, Gangadhar BN, Channabasavanna SM, et al. Carbamazepine hastens therapeutic action of lithium in mania. In: Proceedings of the 1st International Conference on New Directions in Affective Disorders; April 1987
38. Kramlinger KG, Post RM. Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatr Scand 1989;79:378-385
39. Keck PE Jr, McElroy SL, Nemeroff CB. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:395-405
40. Adelson R, Vanloy WJ, Hepburn K. Performance change in an organizational setting: a conceptual model. Journal of Continuing Education in the Health Professions 1997;17:69-80